{"id": "article-158627_0", "title": "Epidermolysis Bullosa -- Introduction", "content": "Epidermolysis bullosa (EB) defines\u00a0a prototypic group of rare, inherited dermatoses, characteristically featuring skin fragility secondary to structural\u00a0defects in the dermo-epidermal junction. This skin fragility creates an impaired tolerance to mechanical stress. Trivial\u00a0mechanical trauma and shear stress can provoke skin blistering, erosions, and ulceration. [1] This places patients with certain forms of\u00a0epidermolysis bullosa at a greater risk of infection, disabling deformities secondary to heavy scarring, and\u00a0aggressive cutaneous malignancy,\u00a0leading to early fatality in some cases. An extensive phenotypic range is described, ranging from fragility and blistering localized to areas of weight-bearing or pressure to widespread generalized involvement, including extracutaneous disease. Thus, certain subtypes of EB confer high morbidity, with a risk of increased mortality due to\u00a0multi-system\u00a0pathology. [2] [3]", "contents": "Epidermolysis Bullosa -- Introduction. Epidermolysis bullosa (EB) defines\u00a0a prototypic group of rare, inherited dermatoses, characteristically featuring skin fragility secondary to structural\u00a0defects in the dermo-epidermal junction. This skin fragility creates an impaired tolerance to mechanical stress. Trivial\u00a0mechanical trauma and shear stress can provoke skin blistering, erosions, and ulceration. [1] This places patients with certain forms of\u00a0epidermolysis bullosa at a greater risk of infection, disabling deformities secondary to heavy scarring, and\u00a0aggressive cutaneous malignancy,\u00a0leading to early fatality in some cases. An extensive phenotypic range is described, ranging from fragility and blistering localized to areas of weight-bearing or pressure to widespread generalized involvement, including extracutaneous disease. Thus, certain subtypes of EB confer high morbidity, with a risk of increased mortality due to\u00a0multi-system\u00a0pathology. [2] [3]"}
{"id": "article-158627_1", "title": "Epidermolysis Bullosa -- Introduction", "content": "Sixteen\u00a0genes have been implicated in underpinning at least 30 observed epidermolysis bullosa\u00a0subtypes. Each subtype features varying phenotypic severity and impact on morbidity and mortality. These subtypes have been organized into\u00a04 major groups based\u00a0on the ultrastructural plane within the\u00a0dermo-epidermal junction that the defect impacts: Epidermolysis Bullosa Simplex (EBS) comprises around 70% of all\u00a0epidermolysis bullosa cases and features a fragility defect in the epidermis, mostly inherited in an autosomal dominant pattern. Junctional Epidermolysis Bullosa (JEB) is an autosomal recessive fragility defect seen specifically within the lamina lucida and makes up around 5% of all\u00a0epidermolysis bullosa cases.", "contents": "Epidermolysis Bullosa -- Introduction. Sixteen\u00a0genes have been implicated in underpinning at least 30 observed epidermolysis bullosa\u00a0subtypes. Each subtype features varying phenotypic severity and impact on morbidity and mortality. These subtypes have been organized into\u00a04 major groups based\u00a0on the ultrastructural plane within the\u00a0dermo-epidermal junction that the defect impacts: Epidermolysis Bullosa Simplex (EBS) comprises around 70% of all\u00a0epidermolysis bullosa cases and features a fragility defect in the epidermis, mostly inherited in an autosomal dominant pattern. Junctional Epidermolysis Bullosa (JEB) is an autosomal recessive fragility defect seen specifically within the lamina lucida and makes up around 5% of all\u00a0epidermolysis bullosa cases."}
{"id": "article-158627_2", "title": "Epidermolysis Bullosa -- Introduction", "content": "Dystrophic Epidermolysis Bullosa (DEB) represents around 25% of all\u00a0epidermolysis bullosa cases and may be autosomal dominant or recessive.\u00a0Dystrophic epidermolysis bullosa features a fragility defect below the lamina densa of the basement membrane zone.", "contents": "Epidermolysis Bullosa -- Introduction. Dystrophic Epidermolysis Bullosa (DEB) represents around 25% of all\u00a0epidermolysis bullosa cases and may be autosomal dominant or recessive.\u00a0Dystrophic epidermolysis bullosa features a fragility defect below the lamina densa of the basement membrane zone."}
{"id": "article-158627_3", "title": "Epidermolysis Bullosa -- Introduction", "content": "Kindler Epidermolysis Bullosa (KEB) is the rarest of the\u00a04 major epidermolysis bullosa types inherited in an autosomal recessive pattern. The kindlin-1 protein is affected in Kindler epidermolysis bullosa, resulting in fragility in any plane of the dermo-epidermal junction. Around\u00a0400 cases\u00a0have been\u00a0reported worldwide. [4] Inherited epidermolysis bullosa is distinct from epidermolysis bullosa aquisita, a separate, non-inherited, immunobullous disorder characterized by antibodies against type VII collagen. [1]", "contents": "Epidermolysis Bullosa -- Introduction. Kindler Epidermolysis Bullosa (KEB) is the rarest of the\u00a04 major epidermolysis bullosa types inherited in an autosomal recessive pattern. The kindlin-1 protein is affected in Kindler epidermolysis bullosa, resulting in fragility in any plane of the dermo-epidermal junction. Around\u00a0400 cases\u00a0have been\u00a0reported worldwide. [4] Inherited epidermolysis bullosa is distinct from epidermolysis bullosa aquisita, a separate, non-inherited, immunobullous disorder characterized by antibodies against type VII collagen. [1]"}
{"id": "article-158627_4", "title": "Epidermolysis Bullosa -- Etiology", "content": "As\u00a0epidermolysis bullosa results from defects within the dermo-epidermal junction, it is imperative to appreciate the components of this structure before\u00a0understanding pathophysiology. [5]", "contents": "Epidermolysis Bullosa -- Etiology. As\u00a0epidermolysis bullosa results from defects within the dermo-epidermal junction, it is imperative to appreciate the components of this structure before\u00a0understanding pathophysiology. [5]"}
{"id": "article-158627_5", "title": "Epidermolysis Bullosa -- Etiology", "content": "The epidermis is the uppermost layer of the dermo-epidermal junction and overlies the dermis. The basement membrane zone is found between the lower (basal) layer of the epidermis and the upper (papillary) layer of the dermis. The\u00a0basement membrane zone is multifunctional: it anchors the epidermis to the dermis, provides scaffolding for cellular migration and adhesion, forms a selectively permeable membrane for cells and molecules, and serves as a model for the differentiation, development, repair, and replacement of cells. The\u00a0basement membrane zone\u00a0consists of\u00a02 layers: the lamina lucida, which lies below the basal epidermis, and the lamina densa, which lies below the lamina lucida.", "contents": "Epidermolysis Bullosa -- Etiology. The epidermis is the uppermost layer of the dermo-epidermal junction and overlies the dermis. The basement membrane zone is found between the lower (basal) layer of the epidermis and the upper (papillary) layer of the dermis. The\u00a0basement membrane zone is multifunctional: it anchors the epidermis to the dermis, provides scaffolding for cellular migration and adhesion, forms a selectively permeable membrane for cells and molecules, and serves as a model for the differentiation, development, repair, and replacement of cells. The\u00a0basement membrane zone\u00a0consists of\u00a02 layers: the lamina lucida, which lies below the basal epidermis, and the lamina densa, which lies below the lamina lucida."}
{"id": "article-158627_6", "title": "Epidermolysis Bullosa -- Etiology", "content": "The\u00a0layers of the\u00a0dermo-epidermal junction are dependent on one another, and function as a collective, as opposed to contributing individually. Protein structures are vital in maintaining the position and proximity of the dermo-epidermal junction layers. In epidermolysis bullosa, defective and deficient proteins arising from inherited or de novo genetic mutations result in\u00a0dermo-epidermal junction malfunction. The phenotypic severity is often proportional to the degree of protein deficiency; therefore, relatively small quantities of functional protein reduce phenotypic severity as compared to an absolute loss of protein expression. [6]", "contents": "Epidermolysis Bullosa -- Etiology. The\u00a0layers of the\u00a0dermo-epidermal junction are dependent on one another, and function as a collective, as opposed to contributing individually. Protein structures are vital in maintaining the position and proximity of the dermo-epidermal junction layers. In epidermolysis bullosa, defective and deficient proteins arising from inherited or de novo genetic mutations result in\u00a0dermo-epidermal junction malfunction. The phenotypic severity is often proportional to the degree of protein deficiency; therefore, relatively small quantities of functional protein reduce phenotypic severity as compared to an absolute loss of protein expression. [6]"}
{"id": "article-158627_7", "title": "Epidermolysis Bullosa -- Etiology", "content": "The culmination of this\u00a0dermo-epidermal junction malfunction is skin fragility. Erosions, blistering, and ulceration ensue in response to seemingly disproportionate mechanical trauma. The resultant wounds are frequently persistent, prone to chronic inflammation, susceptible to infection, and are associated with\u00a0significant pruritis, pain, and diminished quality of life. [7]", "contents": "Epidermolysis Bullosa -- Etiology. The culmination of this\u00a0dermo-epidermal junction malfunction is skin fragility. Erosions, blistering, and ulceration ensue in response to seemingly disproportionate mechanical trauma. The resultant wounds are frequently persistent, prone to chronic inflammation, susceptible to infection, and are associated with\u00a0significant pruritis, pain, and diminished quality of life. [7]"}
{"id": "article-158627_8", "title": "Epidermolysis Bullosa -- Epidemiology", "content": "Approximately 70% of\u00a0epidermolysis bullosa is epidermolysis bullosa simplex. Dystrophic epidermolysis bullosa\u00a0accounts for around 25% of all cases, and\u00a0junctional epidermolysis bullosa the remaining 5%.\u00a0Kindler epidermolysis bullosa is notably the rarest of the\u00a04 epidermolysis bullosa types,\u00a0with only around\u00a0400 cases\u00a0reported worldwide. [8] [9]", "contents": "Epidermolysis Bullosa -- Epidemiology. Approximately 70% of\u00a0epidermolysis bullosa is epidermolysis bullosa simplex. Dystrophic epidermolysis bullosa\u00a0accounts for around 25% of all cases, and\u00a0junctional epidermolysis bullosa the remaining 5%.\u00a0Kindler epidermolysis bullosa is notably the rarest of the\u00a04 epidermolysis bullosa types,\u00a0with only around\u00a0400 cases\u00a0reported worldwide. [8] [9]"}
{"id": "article-158627_9", "title": "Epidermolysis Bullosa -- Epidemiology", "content": "Despite the challenges in formally diagnosing\u00a0epidermolysis bullosa in resource-poor settings, robust epidemiological studies agree that\u00a0epidermolysis bullosa prevalence is around\u00a010 per one million population, with incidence\u00a0at around 20 per one million live births. [10] While\u00a0epidermolysis bullosa appears not to be sex-preferential, trials conducted in Scottish and Middle Eastern populations suggest a geographically biased distribution; this is\u00a0thought\u00a0to be attributable to fewer germ lines within small geographical confines, and\u00a0sociocultural influences where consanguineous marriage is more common. [11] [12]", "contents": "Epidermolysis Bullosa -- Epidemiology. Despite the challenges in formally diagnosing\u00a0epidermolysis bullosa in resource-poor settings, robust epidemiological studies agree that\u00a0epidermolysis bullosa prevalence is around\u00a010 per one million population, with incidence\u00a0at around 20 per one million live births. [10] While\u00a0epidermolysis bullosa appears not to be sex-preferential, trials conducted in Scottish and Middle Eastern populations suggest a geographically biased distribution; this is\u00a0thought\u00a0to be attributable to fewer germ lines within small geographical confines, and\u00a0sociocultural influences where consanguineous marriage is more common. [11] [12]"}
{"id": "article-158627_10", "title": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex", "content": "Epidermolysis bullosa simplex\u00a0arises when there is a defect in genes encoding proteins governing epidermal integrity. While\u00a0epidermolysis bullosa simplex can be inherited in an\u00a0autosomal dominant or autosomal recessive pattern, the former is more common.", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex. Epidermolysis bullosa simplex\u00a0arises when there is a defect in genes encoding proteins governing epidermal integrity. While\u00a0epidermolysis bullosa simplex can be inherited in an\u00a0autosomal dominant or autosomal recessive pattern, the former is more common."}
{"id": "article-158627_11", "title": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex", "content": "Several\u00a0epidermolysis bullosa simplex subtypes exist: localized epidermolysis bullosa simplex, severe epidermolysis bullosa simplex, intermediate epidermolysis bullosa simplex, epidermolysis bullosa simplex with mottled pigmentation, migratory circinate epidermolysis bullosa simplex, intermediate epidermolysis bullosa simplex with cardiomyopathy, intermediate epidermolysis bullosa simplex with PLEC mutations, intermediate epidermolysis bullosa simplex with muscular dystrophy, severe epidermolysis bullosa simplex with pyloric atresia, autosomal recessive KRT5 / KRT14 epidermolysis bullosa simplex, BP230 deficient epidermolysis bullosa simplex, exophilin 5 deficient epidermolysis bullosa simplex, and CD151 deficient epidermolysis bullosa simplex. [1]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex. Several\u00a0epidermolysis bullosa simplex subtypes exist: localized epidermolysis bullosa simplex, severe epidermolysis bullosa simplex, intermediate epidermolysis bullosa simplex, epidermolysis bullosa simplex with mottled pigmentation, migratory circinate epidermolysis bullosa simplex, intermediate epidermolysis bullosa simplex with cardiomyopathy, intermediate epidermolysis bullosa simplex with PLEC mutations, intermediate epidermolysis bullosa simplex with muscular dystrophy, severe epidermolysis bullosa simplex with pyloric atresia, autosomal recessive KRT5 / KRT14 epidermolysis bullosa simplex, BP230 deficient epidermolysis bullosa simplex, exophilin 5 deficient epidermolysis bullosa simplex, and CD151 deficient epidermolysis bullosa simplex. [1]"}
{"id": "article-158627_12", "title": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex", "content": "Seven mutated genes ( KRT5 , KRT14 , KLHL24 , PLEC , DST , EXPH5 , CD151 ) have been isolated as causes of epidermolysis bullosa simplex. 75% of epidermolysis bullosa simplex cases\u00a0are due to mutations in genes KRT5 (keratin 5 protein) and KRT14 (keratin 14). [10] Mutated keratin proteins may lack mechanical stiffness (causing proteolysis, cellular stress, and cytolysis) and exhibit thermolability (causing increased blistering in warmer temperatures). [13] PLEC (plectin), DST (dystonin), and EXPH5 (exophilin 5) mutations affect the hemidesmosome and potentially disrupt the keratin cytoskeleton found within basal keratinocytes. Mutated KLHL24 and CD151 cause a more indirect\u00a0disruption of keratin proteostasis. [14]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex. Seven mutated genes ( KRT5 , KRT14 , KLHL24 , PLEC , DST , EXPH5 , CD151 ) have been isolated as causes of epidermolysis bullosa simplex. 75% of epidermolysis bullosa simplex cases\u00a0are due to mutations in genes KRT5 (keratin 5 protein) and KRT14 (keratin 14). [10] Mutated keratin proteins may lack mechanical stiffness (causing proteolysis, cellular stress, and cytolysis) and exhibit thermolability (causing increased blistering in warmer temperatures). [13] PLEC (plectin), DST (dystonin), and EXPH5 (exophilin 5) mutations affect the hemidesmosome and potentially disrupt the keratin cytoskeleton found within basal keratinocytes. Mutated KLHL24 and CD151 cause a more indirect\u00a0disruption of keratin proteostasis. [14]"}
{"id": "article-158627_13", "title": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex", "content": "Epidermolysis bullosa simplex thus presents with blistering, pruritis, pain, nail abnormalities, dyspigmentation, keratoderma, erosions, and scarring. [14] Repeated chronic\u00a0insult to basal keratinocytes is thought to predispose patients to a mildly elevated incidence of basal cell carcinoma. [15] Affected hemidesmosomal proteins may also be expressed in extracutaneous tissues, giving rise to varied manifestations, including cardiomyopathy, respiratory tract stenosis, pyloric atresia, muscular dystrophy, esophageal involvement, and nephropathy. Failure to thrive can also be seen in severely affected children. [1]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Epidermolysis Bullosa Simplex. Epidermolysis bullosa simplex thus presents with blistering, pruritis, pain, nail abnormalities, dyspigmentation, keratoderma, erosions, and scarring. [14] Repeated chronic\u00a0insult to basal keratinocytes is thought to predispose patients to a mildly elevated incidence of basal cell carcinoma. [15] Affected hemidesmosomal proteins may also be expressed in extracutaneous tissues, giving rise to varied manifestations, including cardiomyopathy, respiratory tract stenosis, pyloric atresia, muscular dystrophy, esophageal involvement, and nephropathy. Failure to thrive can also be seen in severely affected children. [1]"}
{"id": "article-158627_14", "title": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa", "content": "Junctional epidermolysis bullosa\u00a0is characterized by blistering within the plane of the lamina lucida. An autosomal recessive inheritance pattern is observed.", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa. Junctional epidermolysis bullosa\u00a0is characterized by blistering within the plane of the lamina lucida. An autosomal recessive inheritance pattern is observed."}
{"id": "article-158627_15", "title": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa", "content": "Eight\u00a0junctional epidermolysis bullosa subtypes have been identified: severe junctional epidermolysis bullosa; intermediate junctional epidermolysis bullosa; junctional epidermolysis bullosa with pyloric atresia; localized junctional epidermolysis bullosa; junctional epidermolysis bullosa inversa; late-onset junctional epidermolysis bullosa; laryngo-onycho-cutaneous syndrome; and junctional epidermolysis bullosa with interstitial lung disease and nephrotic syndrome. [1]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa. Eight\u00a0junctional epidermolysis bullosa subtypes have been identified: severe junctional epidermolysis bullosa; intermediate junctional epidermolysis bullosa; junctional epidermolysis bullosa with pyloric atresia; localized junctional epidermolysis bullosa; junctional epidermolysis bullosa inversa; late-onset junctional epidermolysis bullosa; laryngo-onycho-cutaneous syndrome; and junctional epidermolysis bullosa with interstitial lung disease and nephrotic syndrome. [1]"}
{"id": "article-158627_16", "title": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa", "content": "Seven distinct mutated genes ( LAMA3 , LAMB3 , LAMC2 , COL17A , ITGA6 , ITGB4 , ITGA3 )\u00a0account for junctional epidermolysis bullosa. Mutations in either LAMA3 , LAMB3 , or LAMC2 result in a malfunctioning laminin 332 protein,\u00a0hindering anchoring filament function and keratinocyte migration during wound healing. [16] Additionally, laminin 332\u00a0maintains\u00a0epithelial\u00a0function in the\u00a0brain, eyes, lungs, kidneys, thymus, and gastrointestinal tract, explaining why\u00a0dysfunction produces an array of extracutaneous complications. The absolute absence of laminin 332 in severe junctional epidermolysis bullosa creates\u00a0extreme epithelial fragility, and severe granulation tissue within the airways can cause respiratory compromise, often limiting\u00a0survival beyond\u00a02 years of age. COL17A mutations create faulty collagen XVII proteins, which maintain hair follicle stem cells, melanocyte stem cells, cell mobility, and cell migration; consequently,\u00a0skin atrophy, hair loss, dyspigmentation, and carcinogenesis ensue. [17] Malfunctioning integrin proteins form\u00a0due\u00a0to mutations in ITGA6 , ITGB4 , and ITGA3 genes. The resultant defective proteins alter cell-matrix adhesion, hemidesmosome, and keratinocyte function, ligand banding, and cell signaling, resulting in\u00a0severe mucocutaneous fragility, overgranulation, and nail dystrophy. Their\u00a0malfunction in the gastrointestinal mucosa results in\u00a0pyloric atresia, while their impact on renal podocytes and alveolar epithelial cells\u00a0propagates nephropathy and interstitial lung disease. [18] [19]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa. Seven distinct mutated genes ( LAMA3 , LAMB3 , LAMC2 , COL17A , ITGA6 , ITGB4 , ITGA3 )\u00a0account for junctional epidermolysis bullosa. Mutations in either LAMA3 , LAMB3 , or LAMC2 result in a malfunctioning laminin 332 protein,\u00a0hindering anchoring filament function and keratinocyte migration during wound healing. [16] Additionally, laminin 332\u00a0maintains\u00a0epithelial\u00a0function in the\u00a0brain, eyes, lungs, kidneys, thymus, and gastrointestinal tract, explaining why\u00a0dysfunction produces an array of extracutaneous complications. The absolute absence of laminin 332 in severe junctional epidermolysis bullosa creates\u00a0extreme epithelial fragility, and severe granulation tissue within the airways can cause respiratory compromise, often limiting\u00a0survival beyond\u00a02 years of age. COL17A mutations create faulty collagen XVII proteins, which maintain hair follicle stem cells, melanocyte stem cells, cell mobility, and cell migration; consequently,\u00a0skin atrophy, hair loss, dyspigmentation, and carcinogenesis ensue. [17] Malfunctioning integrin proteins form\u00a0due\u00a0to mutations in ITGA6 , ITGB4 , and ITGA3 genes. The resultant defective proteins alter cell-matrix adhesion, hemidesmosome, and keratinocyte function, ligand banding, and cell signaling, resulting in\u00a0severe mucocutaneous fragility, overgranulation, and nail dystrophy. Their\u00a0malfunction in the gastrointestinal mucosa results in\u00a0pyloric atresia, while their impact on renal podocytes and alveolar epithelial cells\u00a0propagates nephropathy and interstitial lung disease. [18] [19]"}
{"id": "article-158627_17", "title": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa", "content": "Repeated injury in the lamina lucida increases\u00a0squamous cell carcinoma risk, significantly contributing to early mortality in\u00a0the junctional epidermolysis bullosa population. [20] Additionally, the proteins affected in junctional epidermolysis bullosa also play vital roles in\u00a0the odontogenic epithelium; tooth enamel defects are therefore seen in all patients with junctional epidermolysis bullosa. [21]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Junctional Epidermolysis Bullosa. Repeated injury in the lamina lucida increases\u00a0squamous cell carcinoma risk, significantly contributing to early mortality in\u00a0the junctional epidermolysis bullosa population. [20] Additionally, the proteins affected in junctional epidermolysis bullosa also play vital roles in\u00a0the odontogenic epithelium; tooth enamel defects are therefore seen in all patients with junctional epidermolysis bullosa. [21]"}
{"id": "article-158627_18", "title": "Epidermolysis Bullosa -- Pathophysiology -- Dystrophic Epidermolysis Bullosa", "content": "Dystrophic epidermolysis bullosa\u00a0may be inherited in autosomal dominant or recessive patterns, with the latter giving rise to more severe phenotypes. Dystrophic epidermolysis bullosa features fragility below the lamina densa due to mutant COL7A1 (collagen VII protein). [22]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Dystrophic Epidermolysis Bullosa. Dystrophic epidermolysis bullosa\u00a0may be inherited in autosomal dominant or recessive patterns, with the latter giving rise to more severe phenotypes. Dystrophic epidermolysis bullosa features fragility below the lamina densa due to mutant COL7A1 (collagen VII protein). [22]"}
{"id": "article-158627_19", "title": "Epidermolysis Bullosa -- Pathophysiology -- Dystrophic Epidermolysis Bullosa", "content": "Four types of dominant\u00a0dystrophic epidermolysis bullosa have been identified: intermediate dominant\u00a0dystrophic epidermolysis bullosa, localized dominant\u00a0dystrophic epidermolysis bullosa, dominant\u00a0dystrophic epidermolysis bullosa pruriginosa, and self-improving dominant\u00a0dystrophic epidermolysis bullosa. Six types of\u00a0recessive dystrophic epidermolysis bullosa have been identified: intermediate recessive dystrophic epidermolysis bullosa, severe recessive dystrophic epidermolysis bullosa, recessive dystrophic epidermolysis bullosa inversa, localized recessive dystrophic epidermolysis bullosa, recessive dystrophic epidermolysis bullosa pruriginosa, and self-improving recessive dystrophic epidermolysis bullosa. One final subtype, severe dystrophic epidermolysis bullosa, features dominant and recessive compound heterozygosity. [1]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Dystrophic Epidermolysis Bullosa. Four types of dominant\u00a0dystrophic epidermolysis bullosa have been identified: intermediate dominant\u00a0dystrophic epidermolysis bullosa, localized dominant\u00a0dystrophic epidermolysis bullosa, dominant\u00a0dystrophic epidermolysis bullosa pruriginosa, and self-improving dominant\u00a0dystrophic epidermolysis bullosa. Six types of\u00a0recessive dystrophic epidermolysis bullosa have been identified: intermediate recessive dystrophic epidermolysis bullosa, severe recessive dystrophic epidermolysis bullosa, recessive dystrophic epidermolysis bullosa inversa, localized recessive dystrophic epidermolysis bullosa, recessive dystrophic epidermolysis bullosa pruriginosa, and self-improving recessive dystrophic epidermolysis bullosa. One final subtype, severe dystrophic epidermolysis bullosa, features dominant and recessive compound heterozygosity. [1]"}
{"id": "article-158627_20", "title": "Epidermolysis Bullosa -- Pathophysiology -- Dystrophic Epidermolysis Bullosa", "content": "Deficiency in type VII collagen manifests with\u00a0skin fragility, blistering, scarring, milia, and mucosal\u00a0involvement. While all\u00a04 types of\u00a0epidermolysis bullosa cause repeated blistering, dystrophic epidermolysis bullosa features a defect much deeper in the dermo-epidermal junction, propagating profound\u00a0mucocutaneous scarring and\u00a0fibrosis. [23] [24] Eventually, this significantly disables patients with\u00a0contractures and\u00a0pseudosyndactyly and encourages\u00a0aggressive, metastatic\u00a0squamous cell carcinoma\u00a0development, the latter often proving fatal. [25] [26]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Dystrophic Epidermolysis Bullosa. Deficiency in type VII collagen manifests with\u00a0skin fragility, blistering, scarring, milia, and mucosal\u00a0involvement. While all\u00a04 types of\u00a0epidermolysis bullosa cause repeated blistering, dystrophic epidermolysis bullosa features a defect much deeper in the dermo-epidermal junction, propagating profound\u00a0mucocutaneous scarring and\u00a0fibrosis. [23] [24] Eventually, this significantly disables patients with\u00a0contractures and\u00a0pseudosyndactyly and encourages\u00a0aggressive, metastatic\u00a0squamous cell carcinoma\u00a0development, the latter often proving fatal. [25] [26]"}
{"id": "article-158627_21", "title": "Epidermolysis Bullosa -- Pathophysiology -- Kindler Epidermolysis Bullosa", "content": "Kindler epidermolysis bullosa\u00a0is a consequence of an\u00a0autosomal recessive defect\u00a0in the FERMT1 gene, which produces faulty kindlin-1 proteins.\u00a0This alters\u00a0keratinocyte cytoskeleton maintenance and integrin activation. In Kindler epidermolysis bullosa, blistering may occur in any plane of the dermo-epidermal junction. [9]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Kindler Epidermolysis Bullosa. Kindler epidermolysis bullosa\u00a0is a consequence of an\u00a0autosomal recessive defect\u00a0in the FERMT1 gene, which produces faulty kindlin-1 proteins.\u00a0This alters\u00a0keratinocyte cytoskeleton maintenance and integrin activation. In Kindler epidermolysis bullosa, blistering may occur in any plane of the dermo-epidermal junction. [9]"}
{"id": "article-158627_22", "title": "Epidermolysis Bullosa -- Pathophysiology -- Kindler Epidermolysis Bullosa", "content": "Due to defective kindlin-1, cutaneous mechanical trauma propagates cellular stress in keratinocytes.\u00a0Consequently,\u00a0an\u00a0influx of growth factors and cytokines encourages dermal fibroblasts to over-synthesize the extracellular matrix, resulting in\u00a0scarring and fibrosis. Uniquely amongst EB subtypes, Kindler epidermolysis bullosa features photosensitivity, with\u00a0reduced kindlin-1 linked to UVB-mediated apoptosis. [27]", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Kindler Epidermolysis Bullosa. Due to defective kindlin-1, cutaneous mechanical trauma propagates cellular stress in keratinocytes.\u00a0Consequently,\u00a0an\u00a0influx of growth factors and cytokines encourages dermal fibroblasts to over-synthesize the extracellular matrix, resulting in\u00a0scarring and fibrosis. Uniquely amongst EB subtypes, Kindler epidermolysis bullosa features photosensitivity, with\u00a0reduced kindlin-1 linked to UVB-mediated apoptosis. [27]"}
{"id": "article-158627_23", "title": "Epidermolysis Bullosa -- Pathophysiology -- Kindler Epidermolysis Bullosa", "content": "While childhood Kindler epidermolysis bullosa features\u00a0blistering and photosensitivity, these symptoms eventually give way to\u00a0poikiloderma, dyspigmentation, atrophy, erythema, mucocutaneous scarring and palmoplantar hyperkeratosis. Later in adulthood, epithelial cancers complicate Kindler epidermolysis bullosa, with squamous cell carcinoma typically presenting at acral and mucosal sites. [28] Beyond cutaneous expression, patients may suffer from\u00a0gingivitis, esophageal\u00a0stenosis, and colitis due to kindlin-1 protein utility in the\u00a0oral mucosa and gastrointestinal tract.", "contents": "Epidermolysis Bullosa -- Pathophysiology -- Kindler Epidermolysis Bullosa. While childhood Kindler epidermolysis bullosa features\u00a0blistering and photosensitivity, these symptoms eventually give way to\u00a0poikiloderma, dyspigmentation, atrophy, erythema, mucocutaneous scarring and palmoplantar hyperkeratosis. Later in adulthood, epithelial cancers complicate Kindler epidermolysis bullosa, with squamous cell carcinoma typically presenting at acral and mucosal sites. [28] Beyond cutaneous expression, patients may suffer from\u00a0gingivitis, esophageal\u00a0stenosis, and colitis due to kindlin-1 protein utility in the\u00a0oral mucosa and gastrointestinal tract."}
{"id": "article-158627_24", "title": "Epidermolysis Bullosa -- Histopathology", "content": "Standard light microscopy is not relevant in diagnosing epidermolysis bullosa, as insufficient resolution and a failure to discriminate key ultrastructural diagnostic features can lead to misdiagnosis.", "contents": "Epidermolysis Bullosa -- Histopathology. Standard light microscopy is not relevant in diagnosing epidermolysis bullosa, as insufficient resolution and a failure to discriminate key ultrastructural diagnostic features can lead to misdiagnosis."}
{"id": "article-158627_25", "title": "Epidermolysis Bullosa -- History and Physical", "content": "Epidermolysis bullosa initially presents at birth or early childhood. Common presenting complaints include blistering, skin fragility, and non-healing wounds disproportionate to\u00a0mechanical trauma. A family history of similar\u00a0complaints may be present. Additionally, pain\u00a0and pruritis\u00a0are common concerns. Blistering is distributed with bias for\u00a0sites prone to\u00a0pressure and friction, with the hands, feet, buttocks, and knees most susceptible. In neonates, infants, or children, the nappy\u00a0region is\u00a0also susceptible. [29] When\u00a0epidermolysis bullosa is diagnosed later in life, it is milder or localized\u00a0epidermolysis bullosa subtypes that are identified. [30]", "contents": "Epidermolysis Bullosa -- History and Physical. Epidermolysis bullosa initially presents at birth or early childhood. Common presenting complaints include blistering, skin fragility, and non-healing wounds disproportionate to\u00a0mechanical trauma. A family history of similar\u00a0complaints may be present. Additionally, pain\u00a0and pruritis\u00a0are common concerns. Blistering is distributed with bias for\u00a0sites prone to\u00a0pressure and friction, with the hands, feet, buttocks, and knees most susceptible. In neonates, infants, or children, the nappy\u00a0region is\u00a0also susceptible. [29] When\u00a0epidermolysis bullosa is diagnosed later in life, it is milder or localized\u00a0epidermolysis bullosa subtypes that are identified. [30]"}
{"id": "article-158627_26", "title": "Epidermolysis Bullosa -- History and Physical", "content": "As\u00a0epidermolysis bullosa is a genetically heterozygous group of disorders, a\u00a0broad phenotypic range is recognized. [31] The exact\u00a0epidermolysis bullosa subtype dictates symptom distribution and severity. Subtle distinctions in the\u00a0phenotype can be challenging to differentiate by clinical examination alone. Definitive diagnosis may be possible with specialized evaluation, including electron and immunofluorescence microscopy and genetic mutational analyses. Some classical subtypes are easily identifiable:", "contents": "Epidermolysis Bullosa -- History and Physical. As\u00a0epidermolysis bullosa is a genetically heterozygous group of disorders, a\u00a0broad phenotypic range is recognized. [31] The exact\u00a0epidermolysis bullosa subtype dictates symptom distribution and severity. Subtle distinctions in the\u00a0phenotype can be challenging to differentiate by clinical examination alone. Definitive diagnosis may be possible with specialized evaluation, including electron and immunofluorescence microscopy and genetic mutational analyses. Some classical subtypes are easily identifiable:"}
{"id": "article-158627_27", "title": "Epidermolysis Bullosa -- History and Physical", "content": "Acrally distributed blistering with keratoderma is the hallmark of localized epidermolysis bullosa simplex. Confluent\u00a0palmoplantar keratoderma features in severe epidermolysis bullosa simplex, with clustered arcuate herpetiform blisters. Neonates with a hoarse cry who develop overgranulation in the\u00a0perioral, neck, and axillary areas and tooth enamel defects are likely to have junctional epidermolysis bullosa. Severe\u00a0dystrophic epidermolysis bullosa features profound scarring causing microstomia, loss of linguinal papillae, digital contractures, and pseudosyndactyly. Kindler epidermolysis bullosa\u00a0is distinct in displaying photosensitivity and features poikiloderma. [9] [24] [32] The mode of inheritance (and therefore possible subtype) and consanguinity-related risk may be gleaned\u00a0by establishing a thorough family history.", "contents": "Epidermolysis Bullosa -- History and Physical. Acrally distributed blistering with keratoderma is the hallmark of localized epidermolysis bullosa simplex. Confluent\u00a0palmoplantar keratoderma features in severe epidermolysis bullosa simplex, with clustered arcuate herpetiform blisters. Neonates with a hoarse cry who develop overgranulation in the\u00a0perioral, neck, and axillary areas and tooth enamel defects are likely to have junctional epidermolysis bullosa. Severe\u00a0dystrophic epidermolysis bullosa features profound scarring causing microstomia, loss of linguinal papillae, digital contractures, and pseudosyndactyly. Kindler epidermolysis bullosa\u00a0is distinct in displaying photosensitivity and features poikiloderma. [9] [24] [32] The mode of inheritance (and therefore possible subtype) and consanguinity-related risk may be gleaned\u00a0by establishing a thorough family history."}
{"id": "article-158627_28", "title": "Epidermolysis Bullosa -- History and Physical", "content": "As mentioned previously, extracutaneous involvement is an important\u00a0contributor to\u00a0epidermolysis bullosa morbidity and mortality. The manifestations, as\u00a0outlined in Figure 1, are varied, and their combination and severity are\u00a0governed\u00a0by specific genotypes. [2] [3] Given the broad phenotypic range seen in extracutaneous disease, including a detailed history and\u00a0physical examination is imperative. This will inform both the assessment and plan for treating clinicians.", "contents": "Epidermolysis Bullosa -- History and Physical. As mentioned previously, extracutaneous involvement is an important\u00a0contributor to\u00a0epidermolysis bullosa morbidity and mortality. The manifestations, as\u00a0outlined in Figure 1, are varied, and their combination and severity are\u00a0governed\u00a0by specific genotypes. [2] [3] Given the broad phenotypic range seen in extracutaneous disease, including a detailed history and\u00a0physical examination is imperative. This will inform both the assessment and plan for treating clinicians."}
{"id": "article-158627_29", "title": "Epidermolysis Bullosa -- Evaluation -- Transmission Electron Microscopy and Immunofluorescence Antigen Mapping", "content": "Transmission electron microscopy and immunofluorescence antigen mapping are undertaken upon shave biopsy specimens from non-blistered skin subjected to gentle friction before the study. This is to induce progressive morphological changes of early blistering.\u00a0Blistered skin is not used as reparative changes can lead to misdiagnosis. [33]", "contents": "Epidermolysis Bullosa -- Evaluation -- Transmission Electron Microscopy and Immunofluorescence Antigen Mapping. Transmission electron microscopy and immunofluorescence antigen mapping are undertaken upon shave biopsy specimens from non-blistered skin subjected to gentle friction before the study. This is to induce progressive morphological changes of early blistering.\u00a0Blistered skin is not used as reparative changes can lead to misdiagnosis. [33]"}
{"id": "article-158627_30", "title": "Epidermolysis Bullosa -- Evaluation -- Transmission Electron Microscopy and Immunofluorescence Antigen Mapping", "content": "Following a biopsy, transmission electron microscopy, and\u00a0immunofluorescence antigen mapping are vital in distinguishing\u00a0the affected\u00a0dermo-epidermal junction plane and morphological features specific to\u00a0epidermolysis bullosa\u00a0subtypes. Transmission electron microscopy details the planar location of the dermo-epidermal junction defect and morphological features (desmosomes, hemidesmosomes, anchoring filaments, fibrils, sub-basal dense plates, basal keratin filaments) aiding subtype diagnosis. [34] Conventional light microscopy reveals fewer fine details at the basement membrane zone and, therefore, has no diagnostic role in the setting of epidermolysis bullosa.\u00a0Immunofluorescence antigen mapping\u00a0and transmission electron microscopy\u00a0help\u00a0subtype epidermolysis bullosa by highlighting target antigens and quantifying their abundance (which shows a correlation with phenotypic severity). [35] Limitations of these processes are appreciated in resource-poor settings, given the cost, time, and expertise required.", "contents": "Epidermolysis Bullosa -- Evaluation -- Transmission Electron Microscopy and Immunofluorescence Antigen Mapping. Following a biopsy, transmission electron microscopy, and\u00a0immunofluorescence antigen mapping are vital in distinguishing\u00a0the affected\u00a0dermo-epidermal junction plane and morphological features specific to\u00a0epidermolysis bullosa\u00a0subtypes. Transmission electron microscopy details the planar location of the dermo-epidermal junction defect and morphological features (desmosomes, hemidesmosomes, anchoring filaments, fibrils, sub-basal dense plates, basal keratin filaments) aiding subtype diagnosis. [34] Conventional light microscopy reveals fewer fine details at the basement membrane zone and, therefore, has no diagnostic role in the setting of epidermolysis bullosa.\u00a0Immunofluorescence antigen mapping\u00a0and transmission electron microscopy\u00a0help\u00a0subtype epidermolysis bullosa by highlighting target antigens and quantifying their abundance (which shows a correlation with phenotypic severity). [35] Limitations of these processes are appreciated in resource-poor settings, given the cost, time, and expertise required."}
{"id": "article-158627_31", "title": "Epidermolysis Bullosa -- Evaluation -- Genetic\u00a0Screening", "content": "Genetic screening can confirm the epidermolysis bullosa subtype. Next-generation sequencing has surpassed\u00a0Sanger sequencing in\u00a0epidermolysis bullosa diagnosis due to its lower cost, concurrent multiple gene screening efficiency, and\u00a0operator-friendly data synthesis. [36] [37] Mutational analyses also underpin genetic counseling for family members and may inform future family planning.", "contents": "Epidermolysis Bullosa -- Evaluation -- Genetic\u00a0Screening. Genetic screening can confirm the epidermolysis bullosa subtype. Next-generation sequencing has surpassed\u00a0Sanger sequencing in\u00a0epidermolysis bullosa diagnosis due to its lower cost, concurrent multiple gene screening efficiency, and\u00a0operator-friendly data synthesis. [36] [37] Mutational analyses also underpin genetic counseling for family members and may inform future family planning."}
{"id": "article-158627_32", "title": "Epidermolysis Bullosa -- Treatment / Management", "content": "The absence of curative therapies has led to medical management oriented on supportive care, symptom control, and prevention of mild to severe complications. [29] Interdisciplinary management is necessary, guided by the subtype of EB that is diagnosed.", "contents": "Epidermolysis Bullosa -- Treatment / Management. The absence of curative therapies has led to medical management oriented on supportive care, symptom control, and prevention of mild to severe complications. [29] Interdisciplinary management is necessary, guided by the subtype of EB that is diagnosed."}
{"id": "article-158627_33", "title": "Epidermolysis Bullosa -- Treatment / Management", "content": "In epidermolysis bullosa, blisters are prevented by reducing exposure to\u00a0mechanical\u00a0trauma. Trauma provoked by\u00a0cord clamps, clothing labels and seams, plastic patient identifying bands, and heel prick tests should be minimized in neonates. Hot, humid environments may also aggravate fragility. [38] Trauma-preventative dressings placed over body sites are more likely to meet with pressure or friction. Blisters\u00a0may be pierced with sterile needles and drained, with the blister roof kept intact to\u00a0minimize pain and prevent microbial colonization. Broken skin can be dressed with specialized non-adhesive foam and lipocolloid dressings. [39]", "contents": "Epidermolysis Bullosa -- Treatment / Management. In epidermolysis bullosa, blisters are prevented by reducing exposure to\u00a0mechanical\u00a0trauma. Trauma provoked by\u00a0cord clamps, clothing labels and seams, plastic patient identifying bands, and heel prick tests should be minimized in neonates. Hot, humid environments may also aggravate fragility. [38] Trauma-preventative dressings placed over body sites are more likely to meet with pressure or friction. Blisters\u00a0may be pierced with sterile needles and drained, with the blister roof kept intact to\u00a0minimize pain and prevent microbial colonization. Broken skin can be dressed with specialized non-adhesive foam and lipocolloid dressings. [39]"}
{"id": "article-158627_34", "title": "Epidermolysis Bullosa -- Treatment / Management", "content": "To reduce colonization, antiseptic washes, and ointments may be encouraged. Targeted antibiotic use should be reserved for proven infection, frank cellulitis, and sepsis management. [40] Wound overgranulation may be\u00a0managed with short-term topical corticosteroid use. [41]", "contents": "Epidermolysis Bullosa -- Treatment / Management. To reduce colonization, antiseptic washes, and ointments may be encouraged. Targeted antibiotic use should be reserved for proven infection, frank cellulitis, and sepsis management. [40] Wound overgranulation may be\u00a0managed with short-term topical corticosteroid use. [41]"}
{"id": "article-158627_35", "title": "Epidermolysis Bullosa -- Treatment / Management", "content": "Squamous cell carcinoma\u00a0is frequently a devastating complication in epidermolysis bullosa and notably a common cause of\u00a0early mortality\u00a0in\u00a0junctional epidermolysis bullosa and\u00a0dystrophic epidermolysis bullosa populations. [42] Wide local excision\u00a0remains the recommended management; however,\u00a0squamous cell carcinoma\u00a0in\u00a0epidermolysis bullosa is aggressive and highly metastatic regardless of conventional tumor histological grading or margin of surgical clearance. In severe recessive dystrophic epidermolysis bullosa, the risk of mortality due to\u00a0squamous cell carcinoma\u00a0rises\u00a0to\u00a078.8%\u00a0at 55 years old from\u00a038.7%\u00a0at 35 years old, and the median survival\u00a0is approximately\u00a05 years following initial\u00a0squamous cell carcinoma diagnosis. [15] Radiotherapy and chemotherapy can form palliative treatment options.\u00a0Newer immunotherapy agents have been employed with varying degrees of success.", "contents": "Epidermolysis Bullosa -- Treatment / Management. Squamous cell carcinoma\u00a0is frequently a devastating complication in epidermolysis bullosa and notably a common cause of\u00a0early mortality\u00a0in\u00a0junctional epidermolysis bullosa and\u00a0dystrophic epidermolysis bullosa populations. [42] Wide local excision\u00a0remains the recommended management; however,\u00a0squamous cell carcinoma\u00a0in\u00a0epidermolysis bullosa is aggressive and highly metastatic regardless of conventional tumor histological grading or margin of surgical clearance. In severe recessive dystrophic epidermolysis bullosa, the risk of mortality due to\u00a0squamous cell carcinoma\u00a0rises\u00a0to\u00a078.8%\u00a0at 55 years old from\u00a038.7%\u00a0at 35 years old, and the median survival\u00a0is approximately\u00a05 years following initial\u00a0squamous cell carcinoma diagnosis. [15] Radiotherapy and chemotherapy can form palliative treatment options.\u00a0Newer immunotherapy agents have been employed with varying degrees of success."}
{"id": "article-158627_36", "title": "Epidermolysis Bullosa -- Treatment / Management", "content": "Pain is an important overarching symptom. [43] The source of pain may be the cutaneous disease, the extracutaneous manifestations, or secondary to wound dressing changes or bathing. Analgesia, involvement of\u00a0a pain management team, and psychological support should aim to reduce pain, which frequently debilitates a patient's quality of life. Neuropathic pain medication can play a role in managing pruritic pain symptoms unresolved by emollient, topical corticosteroid, and antihistamine therapy. [44]", "contents": "Epidermolysis Bullosa -- Treatment / Management. Pain is an important overarching symptom. [43] The source of pain may be the cutaneous disease, the extracutaneous manifestations, or secondary to wound dressing changes or bathing. Analgesia, involvement of\u00a0a pain management team, and psychological support should aim to reduce pain, which frequently debilitates a patient's quality of life. Neuropathic pain medication can play a role in managing pruritic pain symptoms unresolved by emollient, topical corticosteroid, and antihistamine therapy. [44]"}
{"id": "article-158627_37", "title": "Epidermolysis Bullosa -- Treatment / Management", "content": "Very recently,\u00a0beremagene geperpavec ('B-VEC'), a\u00a0dosable topical gene therapy delivering COL7A1 using\u00a0herpes simplex virus type 1 as a vector, has\u00a0been approved by the FDA as a treatment for dystrophic epidermolysis bullosa. [45] Similarly, Oleogel-S10 (birch triterpene extract), a herbal gel remedy was recently approved by some regulatory authorities for wound management in junctional and dystrophic epidermolysis bullosa.", "contents": "Epidermolysis Bullosa -- Treatment / Management. Very recently,\u00a0beremagene geperpavec ('B-VEC'), a\u00a0dosable topical gene therapy delivering COL7A1 using\u00a0herpes simplex virus type 1 as a vector, has\u00a0been approved by the FDA as a treatment for dystrophic epidermolysis bullosa. [45] Similarly, Oleogel-S10 (birch triterpene extract), a herbal gel remedy was recently approved by some regulatory authorities for wound management in junctional and dystrophic epidermolysis bullosa."}
{"id": "article-158627_38", "title": "Epidermolysis Bullosa -- Differential Diagnosis", "content": "It is essential to rule out possible differential diagnoses, particularly in neonatal populations: Pompholyx Eczema presents with acral pruritic blistering. A history of atopy may be present. Patch testing may be indicated to identify delayed hypersensitivity reactions to contact allergens. [46] Porphyria presents with scarring, milia, and photosensitivity, with possible hypertrichosis. Skin biopsies and porphyrin testing may be indicated. [47] Bullous Pemphigoid presents with large, tense bullae and itch. Clinical examination and skin biopsy can confirm bullous pemphigoid. [48] Bullous Systemic Lupus Erythematosus presents with tense vesicles, bullae, and erosions, often in sun-exposed areas. Histopathology and immunofluorescence confirm this differential. [49] Bullous Tinea Pedis presents with multilocular pedal blistering, with possible skin maceration between digits. Tinea pedis is diagnosed through mycological cultures from skin scrapings. [50]", "contents": "Epidermolysis Bullosa -- Differential Diagnosis. It is essential to rule out possible differential diagnoses, particularly in neonatal populations: Pompholyx Eczema presents with acral pruritic blistering. A history of atopy may be present. Patch testing may be indicated to identify delayed hypersensitivity reactions to contact allergens. [46] Porphyria presents with scarring, milia, and photosensitivity, with possible hypertrichosis. Skin biopsies and porphyrin testing may be indicated. [47] Bullous Pemphigoid presents with large, tense bullae and itch. Clinical examination and skin biopsy can confirm bullous pemphigoid. [48] Bullous Systemic Lupus Erythematosus presents with tense vesicles, bullae, and erosions, often in sun-exposed areas. Histopathology and immunofluorescence confirm this differential. [49] Bullous Tinea Pedis presents with multilocular pedal blistering, with possible skin maceration between digits. Tinea pedis is diagnosed through mycological cultures from skin scrapings. [50]"}
{"id": "article-158627_39", "title": "Epidermolysis Bullosa -- Differential Diagnosis", "content": "Palmoplantar Keratoderma causes\u00a0acral skin thickening, often with nail dystrophy. Genetic testing may be indicated, though acquired palmoplantar keratoderma may be associated with internal malignancy, thyroid abnormalities, inflammatory dermatoses such as lichen planus, and certain medications. [51]", "contents": "Epidermolysis Bullosa -- Differential Diagnosis. Palmoplantar Keratoderma causes\u00a0acral skin thickening, often with nail dystrophy. Genetic testing may be indicated, though acquired palmoplantar keratoderma may be associated with internal malignancy, thyroid abnormalities, inflammatory dermatoses such as lichen planus, and certain medications. [51]"}
{"id": "article-158627_40", "title": "Epidermolysis Bullosa -- Differential Diagnosis", "content": "Epidermolysis Bullosa Acquisita is an autoimmune disorder that may present similarly to dystrophic epidermolysis bullosa but later in life. Immunofluorescence studies on skin biopsies are indicated. [52] Ehlers-Danlos Syndrome features joint hypermobility, hyperextensible skin, and easy bruising with skin fragility. Ehlers Danlos is diagnosed by skin biopsy and genetic testing. [53] Incontinentia Pigmenti features Blaschkoid vesicles forming hyperpigmented verrucous whorls. [54]", "contents": "Epidermolysis Bullosa -- Differential Diagnosis. Epidermolysis Bullosa Acquisita is an autoimmune disorder that may present similarly to dystrophic epidermolysis bullosa but later in life. Immunofluorescence studies on skin biopsies are indicated. [52] Ehlers-Danlos Syndrome features joint hypermobility, hyperextensible skin, and easy bruising with skin fragility. Ehlers Danlos is diagnosed by skin biopsy and genetic testing. [53] Incontinentia Pigmenti features Blaschkoid vesicles forming hyperpigmented verrucous whorls. [54]"}
{"id": "article-158627_41", "title": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials", "content": "Current clinical trials study the potential of\u00a0a broad range of therapeutic strategies. [55]", "contents": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials. Current clinical trials study the potential of\u00a0a broad range of therapeutic strategies. [55]"}
{"id": "article-158627_42", "title": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials", "content": "Studies on gene replacement therapy explore how COL7A1 can be delivered cutaneously to\u00a0patients with recessive dystrophic epidermolysis bullosa. [56] Recently,\u00a0beremagene geperpavec ('B-VEC'), a topical gene therapy delivering COL7A1 using\u00a0herpes simplex virus type 1 as a vector, has\u00a0been approved by regulatory authorities. [45] Other gene replacement therapy trials explore the efficacy\u00a0of COL7A1 transgenes and self-inactivating viral vectors\u00a0expressing\u00a0type VII\u00a0collagen, which 'correct' cells ex-vivo before being reintroduced to patients cutaneously.\u00a0Studies examining the effectiveness of grafting revertant skin to lesions in\u00a0junctional epidermolysis bullosa suggest the potential of revertant mosaicism as a natural gene replacement therapy. [57] CRISPR/Cas9 technology has shown promise in gene-editing studies involving correcting COL7A1 mutations in fibroblasts and keratinocytes in mice. [58] Pre-clinical studies on exon-skipping in COL7A1 and COL17A1 genes show the effective formation of partly-functioning proteins, indicating another potential therapeutic strategy. [55] The use of induced pluripotent stem cells can encourage the expansion of genetically altered cells ex-vivo to produce sufficient skin grafts for patients. [59]", "contents": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials. Studies on gene replacement therapy explore how COL7A1 can be delivered cutaneously to\u00a0patients with recessive dystrophic epidermolysis bullosa. [56] Recently,\u00a0beremagene geperpavec ('B-VEC'), a topical gene therapy delivering COL7A1 using\u00a0herpes simplex virus type 1 as a vector, has\u00a0been approved by regulatory authorities. [45] Other gene replacement therapy trials explore the efficacy\u00a0of COL7A1 transgenes and self-inactivating viral vectors\u00a0expressing\u00a0type VII\u00a0collagen, which 'correct' cells ex-vivo before being reintroduced to patients cutaneously.\u00a0Studies examining the effectiveness of grafting revertant skin to lesions in\u00a0junctional epidermolysis bullosa suggest the potential of revertant mosaicism as a natural gene replacement therapy. [57] CRISPR/Cas9 technology has shown promise in gene-editing studies involving correcting COL7A1 mutations in fibroblasts and keratinocytes in mice. [58] Pre-clinical studies on exon-skipping in COL7A1 and COL17A1 genes show the effective formation of partly-functioning proteins, indicating another potential therapeutic strategy. [55] The use of induced pluripotent stem cells can encourage the expansion of genetically altered cells ex-vivo to produce sufficient skin grafts for patients. [59]"}
{"id": "article-158627_43", "title": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials", "content": "Repurposing existing therapies has also shown promise. When repurposed for junctional and dystrophic epidermolysis bullosa treatment, gentamycin, an aminoglycoside antibiotic, can 'read through' stop codon mutations in COL7A1 and LAMB3 when administered topically or intravenously, enabling the synthesis of full-length proteins. [60] [61] Losartan, an angiotensin II receptor blocker,\u00a0has shown improvement in inflammation, fibrosis, and tumor progression\u00a0by altering\u00a0TGF-beta signaling in dystrophic epidermolysis bullosa. [62] A trial investigating the repurposing\u00a0of apremilast (a\u00a0phosphodiesterase type-4 inhibitor currently used in psoriasis management) in epidermolysis bullosa simplex is underway. [63] Oleogel-S10 (birch triterpene extract), a herbal gel remedy recently approved by regulating authorities for junctional and dystrophic epidermolysis bullosa management, has demonstrated accelerated wound healing by altering pro-inflammatory mediator regulation, increasing migration of primary human keratinocytes and promoting keratinocyte differentiation. [64] [65]", "contents": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials. Repurposing existing therapies has also shown promise. When repurposed for junctional and dystrophic epidermolysis bullosa treatment, gentamycin, an aminoglycoside antibiotic, can 'read through' stop codon mutations in COL7A1 and LAMB3 when administered topically or intravenously, enabling the synthesis of full-length proteins. [60] [61] Losartan, an angiotensin II receptor blocker,\u00a0has shown improvement in inflammation, fibrosis, and tumor progression\u00a0by altering\u00a0TGF-beta signaling in dystrophic epidermolysis bullosa. [62] A trial investigating the repurposing\u00a0of apremilast (a\u00a0phosphodiesterase type-4 inhibitor currently used in psoriasis management) in epidermolysis bullosa simplex is underway. [63] Oleogel-S10 (birch triterpene extract), a herbal gel remedy recently approved by regulating authorities for junctional and dystrophic epidermolysis bullosa management, has demonstrated accelerated wound healing by altering pro-inflammatory mediator regulation, increasing migration of primary human keratinocytes and promoting keratinocyte differentiation. [64] [65]"}
{"id": "article-158627_44", "title": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials", "content": "Ongoing protein therapy studies observe the efficacy of\u00a0topical and intravenous recombinant type VII collagen in\u00a0promoting wound healing, and HMGB1 proteins in\u00a0suppressing inflammation by mobilizing cells from the bone marrow to damaged tissue. [66] [67] [66]", "contents": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials. Ongoing protein therapy studies observe the efficacy of\u00a0topical and intravenous recombinant type VII collagen in\u00a0promoting wound healing, and HMGB1 proteins in\u00a0suppressing inflammation by mobilizing cells from the bone marrow to damaged tissue. [66] [67] [66]"}
{"id": "article-158627_45", "title": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials", "content": "Literature on the management of squamous cell carcinoma in epidermolysis bullosa is limited. Case studies indicate that cetuximab, an epidermal growth factor receptor inhibitor, increases progression-free survival of head and neck squamous cell carcinoma. [68] Meanwhile, little research exists on the effectiveness of immune checkpoint inhibitors, such as\u00a0nivolumab, pembrolizumab, and cemiplimab. [55] Rigosertib, a multikinase inhibitor, has so far shown successful apoptosis induction in recessive epidermolysis bullosa without impact on carcinoma-free keratinocytes. [69]", "contents": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials. Literature on the management of squamous cell carcinoma in epidermolysis bullosa is limited. Case studies indicate that cetuximab, an epidermal growth factor receptor inhibitor, increases progression-free survival of head and neck squamous cell carcinoma. [68] Meanwhile, little research exists on the effectiveness of immune checkpoint inhibitors, such as\u00a0nivolumab, pembrolizumab, and cemiplimab. [55] Rigosertib, a multikinase inhibitor, has so far shown successful apoptosis induction in recessive epidermolysis bullosa without impact on carcinoma-free keratinocytes. [69]"}
{"id": "article-158627_46", "title": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials", "content": "Advancement in\u00a0epidermolysis bullosa trials requires a focus on\u00a0epidermolysis bullosa severity scoring. While numerous severity scoring tools exist, the absence of a universally utilized tool creates\u00a0discord when comparing epidermolysis bullosa\u00a0severity and assessing symptomatic progression and remission. [70] A global initiative to develop a universal tool is in progress.", "contents": "Epidermolysis Bullosa -- Pertinent Studies and Ongoing Trials. Advancement in\u00a0epidermolysis bullosa trials requires a focus on\u00a0epidermolysis bullosa severity scoring. While numerous severity scoring tools exist, the absence of a universally utilized tool creates\u00a0discord when comparing epidermolysis bullosa\u00a0severity and assessing symptomatic progression and remission. [70] A global initiative to develop a universal tool is in progress."}
{"id": "article-158627_47", "title": "Epidermolysis Bullosa -- Prognosis", "content": "The prognosis in\u00a0epidermolysis bullosa is variable and dictated by the specific causative subtype and the complications arising from cutaneous and extracutaneous manifestations. [71] In some subtypes, particularly those that are milder,\u00a0epidermolysis bullosa has\u00a0minimal impact on life expectancy. In other, more severe subtypes, infantile\u00a0or childhood mortality is highly prevalent. For example, most patients with severe\u00a0junctional epidermolysis bullosa will rarely survive beyond\u00a02 years of age, and severe\u00a0recessive dystrophic epidermolysis bullosa patients often face mortality in the third to fifth decades of life due to the development of aggressive squamous cell carcinoma. [72] [73]", "contents": "Epidermolysis Bullosa -- Prognosis. The prognosis in\u00a0epidermolysis bullosa is variable and dictated by the specific causative subtype and the complications arising from cutaneous and extracutaneous manifestations. [71] In some subtypes, particularly those that are milder,\u00a0epidermolysis bullosa has\u00a0minimal impact on life expectancy. In other, more severe subtypes, infantile\u00a0or childhood mortality is highly prevalent. For example, most patients with severe\u00a0junctional epidermolysis bullosa will rarely survive beyond\u00a02 years of age, and severe\u00a0recessive dystrophic epidermolysis bullosa patients often face mortality in the third to fifth decades of life due to the development of aggressive squamous cell carcinoma. [72] [73]"}
{"id": "article-158627_48", "title": "Epidermolysis Bullosa -- Complications", "content": "Interprofessional discussion should be prompted following diagnosis,\u00a0guided by the specific extracutaneous complications present in the patient.", "contents": "Epidermolysis Bullosa -- Complications. Interprofessional discussion should be prompted following diagnosis,\u00a0guided by the specific extracutaneous complications present in the patient."}
{"id": "article-158627_49", "title": "Epidermolysis Bullosa -- Complications -- Oral and Gastrointestinal Disease", "content": "Repeated blistering, erosion, ulceration, and scarring in the oral mucosa secondary to dysfunctional\u00a0laminin 332, kindlin-1, and\u00a0types VII and XVII collagen can cause microstomia, tongue-tethering and vestibular sulcus loss.\u00a0Junctional epidermolysis bullosa additionally features tooth enamel defect. Combined, these concerns increase the likelihood of dental caries formation due to difficulty maintaining oral hygiene. [74] [75] Management may\u00a0include dental scaling, root planning, and antibiotic therapy.", "contents": "Epidermolysis Bullosa -- Complications -- Oral and Gastrointestinal Disease. Repeated blistering, erosion, ulceration, and scarring in the oral mucosa secondary to dysfunctional\u00a0laminin 332, kindlin-1, and\u00a0types VII and XVII collagen can cause microstomia, tongue-tethering and vestibular sulcus loss.\u00a0Junctional epidermolysis bullosa additionally features tooth enamel defect. Combined, these concerns increase the likelihood of dental caries formation due to difficulty maintaining oral hygiene. [74] [75] Management may\u00a0include dental scaling, root planning, and antibiotic therapy."}
{"id": "article-158627_50", "title": "Epidermolysis Bullosa -- Complications -- Oral and Gastrointestinal Disease", "content": "Nutrition is impacted by the aforementioned oral manifestations, as well as gastrointestinal involvement. Esophageal blistering contributes to poor nutrition by causing dysphagia. This is managed using analgesia, soft diet alteration, and occasionally inhaled steroids to reduce localized edema and erosion. Esophageal webbing and stricturing (including secondary to\u00a0squamous cell carcinoma\u00a0formation)\u00a0hinder proper nutrition due to\u00a0dysphagia and reflux symptoms. Non-malignant esophageal complications may warrant balloon dilation and proton pump inhibitor therapy. [76] Neonatal patients with pyloric atresia cannot develop nutrition at all without immediate surgical intervention. [77] Failure to thrive may be seen, together with vitamin and mineral deficiencies, anemia, hypoalbuminemia, delayed puberty, and poor wound healing. Long-term management warrants specialist dietician support and consideration of gastrostomy placement. [78]", "contents": "Epidermolysis Bullosa -- Complications -- Oral and Gastrointestinal Disease. Nutrition is impacted by the aforementioned oral manifestations, as well as gastrointestinal involvement. Esophageal blistering contributes to poor nutrition by causing dysphagia. This is managed using analgesia, soft diet alteration, and occasionally inhaled steroids to reduce localized edema and erosion. Esophageal webbing and stricturing (including secondary to\u00a0squamous cell carcinoma\u00a0formation)\u00a0hinder proper nutrition due to\u00a0dysphagia and reflux symptoms. Non-malignant esophageal complications may warrant balloon dilation and proton pump inhibitor therapy. [76] Neonatal patients with pyloric atresia cannot develop nutrition at all without immediate surgical intervention. [77] Failure to thrive may be seen, together with vitamin and mineral deficiencies, anemia, hypoalbuminemia, delayed puberty, and poor wound healing. Long-term management warrants specialist dietician support and consideration of gastrostomy placement. [78]"}
{"id": "article-158627_51", "title": "Epidermolysis Bullosa -- Complications -- Oral and Gastrointestinal Disease", "content": "Poor nutritional intake, alongside gastrointestinal and cutaneous losses, leads to microcytic or normocytic anemias, notably iron deficiency anemia or anemia of chronic disease. [79] Iron supplementation is an important consideration. Transfusion may be required in symptomatic anemia if iron is depleted.\u00a0Intravenous iron infusion\u00a0is preferred to oral supplementation, which can cause constipation. Other causes of constipation in\u00a0epidermolysis bullosa\u00a0include regular opioid use, poor fiber and fluid intake, and anal blistering. An osmotic laxative and dietary alteration can be prescribed\u00a0prophylactically to manage constipation. [80]", "contents": "Epidermolysis Bullosa -- Complications -- Oral and Gastrointestinal Disease. Poor nutritional intake, alongside gastrointestinal and cutaneous losses, leads to microcytic or normocytic anemias, notably iron deficiency anemia or anemia of chronic disease. [79] Iron supplementation is an important consideration. Transfusion may be required in symptomatic anemia if iron is depleted.\u00a0Intravenous iron infusion\u00a0is preferred to oral supplementation, which can cause constipation. Other causes of constipation in\u00a0epidermolysis bullosa\u00a0include regular opioid use, poor fiber and fluid intake, and anal blistering. An osmotic laxative and dietary alteration can be prescribed\u00a0prophylactically to manage constipation. [80]"}
{"id": "article-158627_52", "title": "Epidermolysis Bullosa -- Complications -- Musculoskeletal Disease", "content": "Patients with\u00a0epidermolysis bullosa have an increased risk of developing osteopenia and osteoporosis due to reduced mobility, unresolved inflammation, vitamin D deficiency, pubertal delay, and chronic opioid exposure. [81] Consequently, vitamin D supplements, physiotherapy, and induction of puberty may be considered\u00a0when managing\u00a0bone health. With regard to soft tissues, repeated blistering may propagate flexion contracture and pseudosyndactyly formation, significantly impacting manual dexterity and gait. Surgical release may be indicated to improve functionality if preventative measures, such as\u00a0digit-separating\u00a0dressings, physiotherapy, and podiatrist involvement, fail. [82] [83] In subtypes with muscular dystrophy, only supportive therapy is recommended. [84]", "contents": "Epidermolysis Bullosa -- Complications -- Musculoskeletal Disease. Patients with\u00a0epidermolysis bullosa have an increased risk of developing osteopenia and osteoporosis due to reduced mobility, unresolved inflammation, vitamin D deficiency, pubertal delay, and chronic opioid exposure. [81] Consequently, vitamin D supplements, physiotherapy, and induction of puberty may be considered\u00a0when managing\u00a0bone health. With regard to soft tissues, repeated blistering may propagate flexion contracture and pseudosyndactyly formation, significantly impacting manual dexterity and gait. Surgical release may be indicated to improve functionality if preventative measures, such as\u00a0digit-separating\u00a0dressings, physiotherapy, and podiatrist involvement, fail. [82] [83] In subtypes with muscular dystrophy, only supportive therapy is recommended. [84]"}
{"id": "article-158627_53", "title": "Epidermolysis Bullosa -- Complications -- Ophthalmic Involvement", "content": "While ophthalmological input is recommended for complications such as blepharitis, erosion, scarring, keratitis, symblepharon, and ectropion, lubricating preparations\u00a0are recommended as prophylactic management.\u00a0Around\u00a06% of patients with\u00a0recessive dystrophic epidermolysis bullosa develop\u00a0blindness due to ophthalmic involvement. [85] [86]", "contents": "Epidermolysis Bullosa -- Complications -- Ophthalmic Involvement. While ophthalmological input is recommended for complications such as blepharitis, erosion, scarring, keratitis, symblepharon, and ectropion, lubricating preparations\u00a0are recommended as prophylactic management.\u00a0Around\u00a06% of patients with\u00a0recessive dystrophic epidermolysis bullosa develop\u00a0blindness due to ophthalmic involvement. [85] [86]"}
{"id": "article-158627_54", "title": "Epidermolysis Bullosa -- Complications -- Genitourinary Involvement", "content": "Genito-urinary\u00a0epidermolysis bullosa involvement includes stenosis of the urethra (causing hydroureter and hydronephrosis if unresolved), for which surgical stenting may be indicated. [87] Vaginal stenosis may also complicate epidermolysis bullosa. [88] Hemodialysis, peritoneal dialysis,\u00a0and eventual transplantation may be warranted in epidermolysis bullosa-related\u00a0IgA nephropathy, post-streptococcal glomerulonephritis, and renal amyloidosis. [89]", "contents": "Epidermolysis Bullosa -- Complications -- Genitourinary Involvement. Genito-urinary\u00a0epidermolysis bullosa involvement includes stenosis of the urethra (causing hydroureter and hydronephrosis if unresolved), for which surgical stenting may be indicated. [87] Vaginal stenosis may also complicate epidermolysis bullosa. [88] Hemodialysis, peritoneal dialysis,\u00a0and eventual transplantation may be warranted in epidermolysis bullosa-related\u00a0IgA nephropathy, post-streptococcal glomerulonephritis, and renal amyloidosis. [89]"}
{"id": "article-158627_55", "title": "Epidermolysis Bullosa -- Complications -- Cardiovascular and Respiratory Involvement", "content": "KLHL mutations causing dilated and hypertrophic cardiomyopathy\u00a0require\u00a0specialist cardiology input. [90] Interstitial lung disease confers a poor prognosis. [91] Laryngeal involvement requires emergent airway management. [92]", "contents": "Epidermolysis Bullosa -- Complications -- Cardiovascular and Respiratory Involvement. KLHL mutations causing dilated and hypertrophic cardiomyopathy\u00a0require\u00a0specialist cardiology input. [90] Interstitial lung disease confers a poor prognosis. [91] Laryngeal involvement requires emergent airway management. [92]"}
{"id": "article-158627_56", "title": "Epidermolysis Bullosa -- Complications -- Psychosocial Impact", "content": "Epidermolysis bullosa\u00a0is a frequently debilitating disease without a cure and has the potential to exert considerable psychological impact. [93] Chronic wounds, pain, itch, reduced mobility, and difficult social interaction can contribute to a markedly reduced quality of life. [26] The societal, familial, and financial consequences extend to caregivers, particularly\u00a0those\u00a0who are also relatives. [94] Psychological\u00a0support may improve the emotional well-being of patients and caregivers.", "contents": "Epidermolysis Bullosa -- Complications -- Psychosocial Impact. Epidermolysis bullosa\u00a0is a frequently debilitating disease without a cure and has the potential to exert considerable psychological impact. [93] Chronic wounds, pain, itch, reduced mobility, and difficult social interaction can contribute to a markedly reduced quality of life. [26] The societal, familial, and financial consequences extend to caregivers, particularly\u00a0those\u00a0who are also relatives. [94] Psychological\u00a0support may improve the emotional well-being of patients and caregivers."}
{"id": "article-158627_57", "title": "Epidermolysis Bullosa -- Deterrence and Patient Education", "content": "As\u00a0epidermolysis bullosa has genetic etiology, only genetic counseling, prenatal screening, and preimplantation screening can inform whether offspring\u00a0could be affected. [95] [96] While genetic counseling predicts the mode of inheritance and the likelihood of\u00a0epidermolysis bullosa transmission to offspring, prenatal screening\u00a0employs chorionic villus sampling or amniocentesis to guide expecting parents on inheritance risk. [97] Chorionic\u00a0villus sampling is an effective method of screening though it carries a higher risk of miscarriage. Preimplantation screening and haplotyping identify mutations in early embryos and oocytes, respectively, allowing for genetically unaffected fertilization. [98]", "contents": "Epidermolysis Bullosa -- Deterrence and Patient Education. As\u00a0epidermolysis bullosa has genetic etiology, only genetic counseling, prenatal screening, and preimplantation screening can inform whether offspring\u00a0could be affected. [95] [96] While genetic counseling predicts the mode of inheritance and the likelihood of\u00a0epidermolysis bullosa transmission to offspring, prenatal screening\u00a0employs chorionic villus sampling or amniocentesis to guide expecting parents on inheritance risk. [97] Chorionic\u00a0villus sampling is an effective method of screening though it carries a higher risk of miscarriage. Preimplantation screening and haplotyping identify mutations in early embryos and oocytes, respectively, allowing for genetically unaffected fertilization. [98]"}
{"id": "article-158627_58", "title": "Epidermolysis Bullosa -- Enhancing Healthcare Team Outcomes", "content": "Given that\u00a0epidermolysis bullosa is presently incurable, the aims of current care are orientated around early and accurate\u00a0diagnosis, information on prognosis, symptom relief, quality of life, prevention of complications, and genetic counseling. [99] Patients are generally managed in many settings. Though\u00a0stable patients\u00a0are\u00a0usually managed in outpatient facilities, acute complications may require specialist assessment.", "contents": "Epidermolysis Bullosa -- Enhancing Healthcare Team Outcomes. Given that\u00a0epidermolysis bullosa is presently incurable, the aims of current care are orientated around early and accurate\u00a0diagnosis, information on prognosis, symptom relief, quality of life, prevention of complications, and genetic counseling. [99] Patients are generally managed in many settings. Though\u00a0stable patients\u00a0are\u00a0usually managed in outpatient facilities, acute complications may require specialist assessment."}
{"id": "article-158627_59", "title": "Epidermolysis Bullosa -- Enhancing Healthcare Team Outcomes", "content": "Based on severity, patients with\u00a0epidermolysis bullosa should\u00a0be scheduled for regular follow-up, at a minimum of annual, coordinated with their primary care clinician. A complete skin examination, with photography to monitor suspicious lesions,\u00a0is recommended. The frequency of home visits by a specialist nurse is\u00a0determined by phenotypic severity. Patients should be prescribed a supply of wound dressings as part of their prescription.", "contents": "Epidermolysis Bullosa -- Enhancing Healthcare Team Outcomes. Based on severity, patients with\u00a0epidermolysis bullosa should\u00a0be scheduled for regular follow-up, at a minimum of annual, coordinated with their primary care clinician. A complete skin examination, with photography to monitor suspicious lesions,\u00a0is recommended. The frequency of home visits by a specialist nurse is\u00a0determined by phenotypic severity. Patients should be prescribed a supply of wound dressings as part of their prescription."}
{"id": "article-158627_60", "title": "Epidermolysis Bullosa -- Enhancing Healthcare Team Outcomes", "content": "The\u00a0epidermolysis bullosa\u00a0team will almost always comprise a dermatologist and specialist nurse in coordination with primary care. There are several key members of the interdisciplinary team, depending on the phenotype, including general practitioners, pediatricians, podiatrists, oncologists, plastic surgeons, palliative care specialists, pain management specialists, psychologists, dentists, ophthalmologists, occupational therapists, physiotherapists, dietitians, gastroenterologists, urologists, speech and language specialists, otolaryngologists, cardiologists, endocrinologists, and orthotics. Multidisciplinary team meetings\u00a0help to coordinate these interspecialty efforts. [98] [100]", "contents": "Epidermolysis Bullosa -- Enhancing Healthcare Team Outcomes. The\u00a0epidermolysis bullosa\u00a0team will almost always comprise a dermatologist and specialist nurse in coordination with primary care. There are several key members of the interdisciplinary team, depending on the phenotype, including general practitioners, pediatricians, podiatrists, oncologists, plastic surgeons, palliative care specialists, pain management specialists, psychologists, dentists, ophthalmologists, occupational therapists, physiotherapists, dietitians, gastroenterologists, urologists, speech and language specialists, otolaryngologists, cardiologists, endocrinologists, and orthotics. Multidisciplinary team meetings\u00a0help to coordinate these interspecialty efforts. [98] [100]"}
{"id": "article-158627_61", "title": "Epidermolysis Bullosa -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Epidermolysis Bullosa -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}